Currency in INR
Earnings estimate | Current qtr. (Jun 2018) | Next qtr. (Sep 2018) | Current year (2019) | Next year (2020) |
---|
No. of analysts | 1 | 1 | 8 | 7 |
Avg. Estimate | 10.6 | 11.44 | 52.33 | 61.73 |
Low estimate | 10.6 | 11.44 | 46 | 57.5 |
High estimate | 10.6 | 11.44 | 64.33 | 68.6 |
Year ago EPS | N/A | 12.95 | 53.25 | 52.33 |
Revenue estimate | Current qtr. (Jun 2018) | Next qtr. (Sep 2018) | Current year (2019) | Next year (2020) |
---|
No. of analysts | 1 | 1 | 8 | 7 |
Avg. Estimate | 4.97B | 5.2B | 21.73B | 24.5B |
Low estimate | 4.97B | 5.2B | 20.6B | 23.4B |
High estimate | 4.97B | 5.2B | 23.83B | 26.2B |
Year ago sales | 4.73B | 5.4B | 21.31B | 21.73B |
Sales growth (year/est) | 5.00% | -3.70% | 2.00% | 12.70% |
Earnings history | Invalid Date | 31/03/2017 | 31/12/2017 | 31/03/2018 |
---|
Est. EPS | N/A | 12.2 | 12 | 12.32 |
Actual EPS | N/A | 12.95 | 16.75 | 10.74 |
Difference | N/A | 0.75 | 4.75 | -1.58 |
Surprise % | N/A | 6.10% | 39.60% | -12.80% |
EPS trend | Current qtr. (Jun 2018) | Next qtr. (Sep 2018) | Current year (2019) | Next year (2020) |
---|
Current estimate | 10.6 | 11.44 | 52.33 | 61.73 |
7 days ago | 10.6 | 11.44 | 52.33 | 61.73 |
30 days ago | 10.6 | 11.44 | 52.33 | 61.73 |
60 days ago | 12.33 | 15.74 | 62.09 | 74.98 |
90 days ago | 12.33 | 15.74 | 62.37 | 74.98 |
EPS revisions | Current qtr. (Jun 2018) | Next qtr. (Sep 2018) | Current year (2019) | Next year (2020) |
---|
Up last 7 days | N/A | N/A | N/A | N/A |
Up last 30 days | N/A | N/A | N/A | N/A |
Down last 7 days | N/A | N/A | N/A | N/A |
Down last 30 days | N/A | N/A | N/A | N/A |
Growth estimates | AJANTPHARM.BO | Industry | Sector(s) | S&P 500 |
---|
Current qtr. | N/A | N/A | N/A | N/A |
Next qtr. | -11.70% | N/A | N/A | N/A |
Current year | -1.70% | N/A | N/A | N/A |
Next year | 18.00% | N/A | N/A | N/A |
Next 5 years (per annum) | -14.50% | N/A | N/A | N/A |
Past 5 years (per annum) | 31.96% | N/A | N/A | N/A |